{"log_id": 8339501083700056636, "direction": 0, "words_result_num": 28, "words_result": [{"probability": {"variance": 0.015393, "average": 0.962805, "min": 0.484341}, "location": {"width": 272, "top": 176, "height": 26, "left": 192}, "words": "核准日期:2013年12月17日"}, {"probability": {"variance": 6e-06, "average": 0.99819, "min": 0.993084}, "location": {"width": 222, "top": 224, "height": 33, "left": 487}, "words": "卡培他滨片说明书"}, {"probability": {"variance": 4e-06, "average": 0.998727, "min": 0.99251}, "location": {"width": 404, "top": 278, "height": 29, "left": 394}, "words": "请仔细阅读说明书并在医师指导下使用"}, {"probability": {"variance": 0.001102, "average": 0.961119, "min": 0.927929}, "location": {"width": 42, "top": 360, "height": 23, "left": 192}, "words": "警告"}, {"probability": {"variance": 0.007891, "average": 0.971745, "min": 0.515735}, "location": {"width": 812, "top": 399, "height": 28, "left": 193}, "words": "对于同时服用卡培他滨和香豆素衍生物抗凝药婚华法令和苯丙香豆素的患者,应该频繁监测"}, {"probability": {"variance": 0.017551, "average": 0.944123, "min": 0.395667}, "location": {"width": 814, "top": 437, "height": 30, "left": 191}, "words": "抗凝反应指标,如R或凝血酶原时间,以调整抗凝剂的量。在食并用药期间,曾有凝"}, {"probability": {"variance": 0.014109, "average": 0.951166, "min": 0.591886}, "location": {"width": 353, "top": 476, "height": 26, "left": 192}, "words": "血参数改变和/或出血,包括死亡的报告"}, {"probability": {"variance": 0.012301, "average": 0.953406, "min": 0.433775}, "location": {"width": 814, "top": 513, "height": 32, "left": 190}, "words": "发生时间:在开始卡培他滨治疗后几天到几个月时间内,也可能在停止使用卡培他滨1"}, {"probability": {"variance": 0, "average": 0.999614, "min": 0.999376}, "location": {"width": 122, "top": 554, "height": 25, "left": 194}, "words": "个月内观察到"}, {"probability": {"variance": 0.018521, "average": 0.958672, "min": 0.433848}, "location": {"width": 298, "top": 591, "height": 29, "left": 192}, "words": "易感因素:年龄>60,诊断为癌"}, {"probability": {"variance": 0.000192, "average": 0.993561, "min": 0.962546}, "location": {"width": 114, "top": 669, "height": 31, "left": 195}, "words": "【药品名称】"}, {"probability": {"variance": 1.9e-05, "average": 0.997412, "min": 0.98827}, "location": {"width": 210, "top": 711, "height": 27, "left": 249}, "words": "通用名称:卡培他滨片"}, {"probability": {"variance": 0.000581, "average": 0.983894, "min": 0.928997}, "location": {"width": 137, "top": 751, "height": 26, "left": 251}, "words": "英文名称:Cap"}, {"probability": {"variance": 9.4e-05, "average": 0.995304, "min": 0.969677}, "location": {"width": 139, "top": 791, "height": 26, "left": 250}, "words": "汉语拼音:Kap"}, {"probability": {"variance": 6.6e-05, "average": 0.994389, "min": 0.980314}, "location": {"width": 72, "top": 828, "height": 25, "left": 195}, "words": "【成份】"}, {"probability": {"variance": 0.011263, "average": 0.961109, "min": 0.626607}, "location": {"width": 232, "top": 868, "height": 27, "left": 250}, "words": "本品主要成份为卡培他滨"}, {"probability": {"variance": 0.012243, "average": 0.952466, "min": 0.418417}, "location": {"width": 495, "top": 907, "height": 28, "left": 250}, "words": "化学名称:5-脱氧-5-氟-N(戊氧基)羰基胞(嘧啶核)苷"}, {"probability": {"variance": 0, "average": 0.999706, "min": 0.998971}, "location": {"width": 107, "top": 947, "height": 26, "left": 249}, "words": "化学结构式"}, {"probability": {"variance": 0.037118, "average": 0.852162, "min": 0.397457}, "location": {"width": 192, "top": 1175, "height": 26, "left": 261}, "words": "分子式:C1s5H22FN3O"}, {"probability": {"variance": 0.01817, "average": 0.937469, "min": 0.544553}, "location": {"width": 137, "top": 1214, "height": 26, "left": 259}, "words": "分子量:359.35"}, {"probability": {"variance": 2e-06, "average": 0.998919, "min": 0.996331}, "location": {"width": 73, "top": 1252, "height": 26, "left": 195}, "words": "【性状】"}, {"probability": {"variance": 7.2e-05, "average": 0.996476, "min": 0.96136}, "location": {"width": 393, "top": 1292, "height": 28, "left": 249}, "words": "本品为桃色薄膜衣片,除去包衣后显类白色"}, {"probability": {"variance": 3e-06, "average": 0.99873, "min": 0.995332}, "location": {"width": 89, "top": 1331, "height": 26, "left": 195}, "words": "【适应症】"}, {"probability": {"variance": 0.000337, "average": 0.991471, "min": 0.912121}, "location": {"width": 786, "top": 1372, "height": 34, "left": 253}, "words": "结肠癌辅助化疗:卡培他滨适用于 dukes' C期、原发肿瘤根治术后、适于接受氟嘧啶"}, {"probability": {"variance": 0.000837, "average": 0.989965, "min": 0.85452}, "location": {"width": 816, "top": 1409, "height": 33, "left": 190}, "words": "类药物单独治疗的结肠癌患者的单药辅助治疗。其治疗的无病生存期(DFS)不亚于5氟尿嘧"}, {"probability": {"variance": 0.002075, "average": 0.980481, "min": 0.79919}, "location": {"width": 814, "top": 1451, "height": 28, "left": 190}, "words": "啶和甲酰四氢叶酸联合方案(5-FU/LV)。卡培他滨单药或与其他药物联合化疗均不能延长总"}, {"probability": {"variance": 0.007216, "average": 0.972563, "min": 0.55137}, "location": {"width": 816, "top": 1489, "height": 32, "left": 189}, "words": "生存期(OS),但已有试验数据表明在联合化疗方案中卡培他滨可较5FU/LV改善无病生存"}, {"probability": {"variance": 0.003572, "average": 0.98036, "min": 0.66771}, "location": {"width": 815, "top": 1528, "height": 32, "left": 190}, "words": "期。医师在开具处方使用卡培他滨对 Dukes C期结肠癌进行辅助治疗时,可参考以上研究"}], "language": 3}